COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 134 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97 | -4.0% | 4,351 | -8.2% | 0.00% | – |
| Q2 2023 | $101 | -75.9% | 4,739 | -72.9% | 0.00% | – |
| Q1 2023 | $419 | -91.6% | 17,483 | +6949.6% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 248 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -87.8% | 248 | -85.9% | 0.00% | – |
| Q1 2021 | $41,000 | +485.7% | 1,759 | +326.9% | 0.00% | – |
| Q2 2020 | $7,000 | -80.6% | 412 | -77.0% | 0.00% | – |
| Q4 2019 | $36,000 | +350.0% | 1,793 | +156.5% | 0.00% | – |
| Q3 2019 | $8,000 | -73.3% | 699 | -70.3% | 0.00% | – |
| Q2 2019 | $30,000 | +900.0% | 2,353 | +901.3% | 0.00% | – |
| Q1 2019 | $3,000 | -78.6% | 235 | -60.3% | 0.00% | – |
| Q2 2018 | $14,000 | -60.0% | 592 | -57.6% | 0.00% | -100.0% |
| Q1 2018 | $35,000 | -47.0% | 1,397 | -61.3% | 0.00% | -33.3% |
| Q4 2017 | $66,000 | +3200.0% | 3,612 | +1305.4% | 0.00% | – |
| Q3 2017 | $2,000 | – | 257 | +559.0% | 0.00% | – |
| Q2 2017 | $0 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $34,840,000 | 5.65% |
| SECTORAL ASSET MANAGEMENT INC | 1,426,862 | $26,340,000 | 3.29% |
| Eventide Asset Management | 2,207,610 | $40,752,000 | 2.12% |
| Rock Springs Capital Management LP | 1,885,729 | $34,811,000 | 1.58% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 460,000 | $8,492,000 | 1.11% |
| Cormorant Asset Management, LP | 300,000 | $5,538,000 | 0.58% |
| HIGHLAND CAPITAL MANAGEMENT LP | 579,234 | $10,693,000 | 0.49% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,389,863 | $25,657,000 | 0.39% |
| NBW CAPITAL LLC | 69,050 | $1,275,000 | 0.34% |
| NEXT CENTURY GROWTH INVESTORS LLC | 144,972 | $2,676,000 | 0.33% |